Pharma Journalist 9027 posts 0 comments

Compugen Ltd. a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, announced the expansion of its clinical collaboration agreement with Bristol…
Read More...

On February 21, 2021, GenScript ProBio and SunRock Biopharma, a company focused on the development of antibody therapeutics targeting cancer, announced a collaboration spanning…
Read More...

Novavax, Inc. a biotechnology company developing next-generation vaccines for serious infectious diseases, announced the complete enrollment of PREVENT-19, its pivotal Phase 3 study in…
Read More...

Sanofi and GlaxoSmithKline (GSK) announced the initiation of a new Phase 2 study with 720 volunteers aged 18 and over to select the most appropriate antigen dosage for Phase 3…
Read More...

AstraZeneca announced the voluntary withdrawal of the Imfinzi (durvalumab) indication in the US for previously treated adult patients with locally advanced or metastatic bladder cancer.…
Read More...

Covectra, a leader in track and trace solutions, announced the next generation of StellaGuard, a smart label and mobile authentication solution that will enable brand managers and…
Read More...

Junshi Biosciences a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced that the National…
Read More...

SMi Group Reports: In the lead up to the 5th Annual Highly Potent Active Pharmaceutical Ingredients Virtual Conference, taking place on 10th-11th May 2021, Justin Mason-Home, HPAPI…
Read More...

Pfizer Inc. and BioNTech SE announced that the first participants have been dosed in a global Phase 2/3 study to further evaluate the safety, tolerability, and immunogenicity of the…
Read More...

Eli Lilly and Company and Rigel Pharmaceuticals, Inc. announced a global exclusive license agreement and strategic collaboration to co-develop and commercialize Rigel's R552, a…
Read More...